Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C)

Published:2024-02-20 Issue:3 Volume:44 Page:183-198
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Bell Christopher F.^ORCID,Bobbili Priyanka^ORCID,Desai Raj^ORCID,Gibbons Daniel C.^ORCID,Drysdale Myriam^ORCID,DerSarkissian Maral^ORCID,Patel Vishal^ORCID,Birch Helen J.^ORCID,Lloyd Emily J.,Zhang Adina^ORCID,Duh Mei Sheng^ORCID,

Funder

GSK Vir Biotechnology, Inc.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40261-024-01344-4.pdf

Reference54 articles.

1. World Health Organization. Coronavirus disease (COVID-19) pandemic. 2022. Available from: https://www.who.int/europe/emergencies/situations/covid-19. Accessed 6 March 2023.

2. World Health Organization. Coronavirus (COVID-19) Dashboard. February 2023. Available from: https://covid19.who.int/. Accessed 6 March 2023.

3. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital surveillances: the epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) – China, 2020. China CDC Wkly. 2020;2(8):113–22.

4. World Health Organization. Living guidance for clinical management of COVID-19. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2. Accessed 6 March 2023.

5. Shadmi E, Chen Y, Dourado I, et al. Health equity and COVID-19: global perspectives. Int J Equity Health. 2020;19(1):104.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP